London [UK], September 12 (ANI): The third phase of AstraZeneca's coronavirus vaccine trial has resumed in the UK, days after it was halted over safety concerns.
New Delhi [India], September 12 (ANI): The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered the pharma giant Serum Institute of India (SII) to suspend any new recruitment in phase 2 and 3 clinical trials for COVID-19 vaccine till further orders.
Mumbai (Maharashtra) [India], September 11 (ANI): Equity benchmark indices closed at near-flat levels on Friday as investors remained cautious about adverse news flow of Covid-19 vaccine trials, simmering India-China geopolitical tensions and a sharp sell-off in US equities.
London [UK], September 10 (ANI/Sputnik): AstraZeneca CEO Pascal Soriot on Wednesday expressed hopes that a vaccine against the novel coronavirus developed by the pharmaceutical company would be ready by the end of 2020 or early 2021, despite having to pause clinical trials.
Sydney [Australia], September 10 (ANI/Xinhua): Australian researchers have developed a new tool to help tackle the problem of mutations in COVID-19, which could render prospective vaccines ineffective.
Brasilia [Brazil], September 10 (ANI/Sputnik): The Brazilian state of Bahia has signed an agreement with Russia for access to data on the Russian COVID-19 vaccine, Sputnik V, and intends to conduct its clinical trials, the Folha de Sao Paulo newspaper reported.
Washington [US], September 10 (ANI/Sputnik): US National Institutes of Health Director Francis Collins told Congress on Wednesday that it is impossible to say if the United States will have a COVID-19 vaccine by the November presidential election, although he is cautiously optimistic one wil
New Delhi [India], September 9 (ANI): Hours after the Drugs Controller General of India (DCGI) issued a show-cause notice Serum Institute of India (SII) asking for an explanation as to why the ongoing clinical trial of Covishield vaccine candidate has not been suspended till doubts about
New Delhi [India], September 9 (ANI): The Drugs Regulator General of India (DCGI) has issued a show-cause notice to pharma giant Serum Institute of India (SII) asking for an explanation as to why the ongoing clinical trial of Covishield vaccine candidate has not been suspended till doubts
New Delhi [India], September 9 (ANI): After AstraZeneca suspended the trials of COVID-19 vaccine in the UK, Indian pharmaceutical giant Serum Institue of India (SII) on Wednesday clarified that testing of the possible vaccine candidate in India is ongoing and has not faced any issue so far.
London [UK], September 9 (ANI): UK-based biopharma giant AstraZeneca has said that the phase 3 testing of its COVID-19 vaccine being developed with Oxford University has been put on hold, due to a suspected serious adverse reaction in a participant in the United Kingdom.
Caracas [Venezuela], September 9 (ANI/Sputnik): Venezuelan President Nicolas Maduro said Russia's Sputnik-V vaccine against the novel coronavirus disease (COVID-19) would be delivered to Venezuela in September 2020 for clinical trials.